Clinical Trial Update: Study of ART6043 in Advanced/Metastatic Solid Tumors Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating ART6043 in patients with advanced/metastatic solid tumors is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ART6043

Snippet

Sponsor: Artios Pharma Ltd | Conditions: Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING